Published in Ann Med on December 01, 1990
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health (2003) 2.46
Blood donation. Lancet (1992) 2.46
Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity. Lancet (1990) 2.06
Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med (2000) 1.60
Absence of the major sialoglycoprotein in the membrane of human En(a--) erythrocytes and increased glycosylation of band 3. J Biol Chem (1976) 1.46
IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies. Br Med J (1974) 1.46
Protein C in the treatment of coagulopathy in meningococcal disease. Crit Care Med (1998) 1.44
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Experimentally induced mononucleosis-like heterophile antibodies in man. Clin Exp Immunol (1969) 1.22
Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d. Complement Inflamm (1989) 1.18
IgA-induced anaphylactic transfusion reactions: a report of four cases. Blood (1973) 1.12
The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project. Atherosclerosis (2001) 1.12
Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies. Acta Paediatr Scand (1988) 1.01
Postural variations of the intraocular pressure as measured with the Mackay-Marg tonometer. Acta Ophthalmol (Copenh) (1967) 0.99
Plasma beta-thromboglobulin in severe infection. Thromb Res (1982) 0.96
Isoantibodies to human IgM: serologic and immunochemical investigations. J Immunol (1971) 0.96
Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk. Atherosclerosis (1999) 0.95
Gammaglobulin treatment and anti-IgA antibodies in IgA-deficient patients. Br Med J (1978) 0.94
Infectious mononucleosis. Semin Hematol (1971) 0.94
Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79. Br J Haematol (1982) 0.93
Studies on the membrane glycoprotein defect of En(a-) erythrocytes. I. Biochemical aspects. J Immunogenet (1976) 0.91
Anaesthesia affects plasma concentrations of vasopressin, von Willebrand factor and coagulation factor VIII in cardiac surgical patients. Br J Anaesth (1993) 0.90
Hepatitis C antibodies in dialysis patients and patients with leukaemia. J Med Virol (1993) 0.85
Heme arginate: effects on hemostasis. Blood (1988) 0.85
Haemostatic and other cardiovascular risk factors, and socioeconomic status among middle-aged Finnish men and women. Int J Epidemiol (1995) 0.84
Cardiopulmonary bypass in a patient with factor XII deficiency. Anesthesiology (1991) 0.83
Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood (1994) 0.83
Risk factors for cryptogenic ischaemic stroke. Eur J Neurol (2002) 0.83
Platelet aggregation by isolated and aggregated human IgG. Clin Exp Immunol (1975) 0.83
Brain anomalies in 121 children with non-syndromic single suture craniosynostosis by MR imaging. Eur J Paediatr Neurol (2012) 0.83
Plasma beta-thromboglobulin in acute myocardial infarction. Thromb Res (1982) 0.82
Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study. Eur Heart J (1994) 0.82
Studies of the nature of incomplete anti-Rh antibodies. Int Arch Allergy Appl Immunol (1967) 0.82
Influence of antigen receptor density on agglutination of red blood cells. Int Arch Allergy Appl Immunol (1970) 0.82
Quantitative aspects of mononucleosis antibodies. Int Arch Allergy Appl Immunol (1968) 0.82
The effect of parenteral estrogen versus orchiectomy on blood coagulation and fibrinolysis in prostatic cancer patients. Eur Urol (1990) 0.82
Epstein-Barr virus-IgM antibody test in infectious mononucleosis. J Infect Dis (1976) 0.81
von Willebrand factor antigen and dental infections. Thromb Res (1989) 0.81
Haemophilia A: two recombinations detected with probe St14. Lancet (1986) 0.81
Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study. Blood Coagul Fibrinolysis (2001) 0.81
Studies on the membrane glycoprotein defect of En(a-) erythrocytes. III. N-terminal amino acids of sialoglycoproteins from normal and En(a-) red cells. J Immunogenet (1978) 0.81
Human antibodies to ruminant IgM concealing the absence of IgA in man. J Lab Clin Med (1971) 0.81
Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res (1986) 0.80
Platelet function in preleukaemia. Scand J Haematol (1981) 0.80
Studies on a crystalline myeloma protein. Immunochemistry (1971) 0.79
The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery. Acta Anaesthesiol Scand (2005) 0.79
New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women. Maturitas (1988) 0.79
ROCK2 allelic variants are not associated with pre-eclampsia susceptibility in the Finnish population. Mol Hum Reprod (2009) 0.79
Platelet function in the myelodysplastic syndromes. Scand J Haematol Suppl (1986) 0.79
Weak anti-IgA antibodies with limited specificity and nonhemolytic transfusion reactions. Vox Sang (1977) 0.78
Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lung. Pharmacol Toxicol (1993) 0.78
Factor V Leiden as a risk factor for preterm birth--a population-based nested case-control study. J Thromb Haemost (2011) 0.78
Hemophilia A: genetic prediction and linkage studies in all available families in Finland. Clin Genet (1991) 0.78
Asymmetric laterality of Chiari type I malformation in patients with non-syndromic single-suture craniosynostosis. Acta Neurochir (Wien) (2012) 0.77
Specificity and sensitivity of two second-generation ELISA tests in detecting hepatitis C antibodies in blood donors known to be reactive with a supplemental assay. Vox Sang (1992) 0.77
Circulating activated protein C in subjects with heterozygous Gln506-factor V. Haemostasis (1999) 0.77
Constitutional translocation t(3;6)(p14;p11) in a family with hematologic malignancies. Cancer Genet Cytogenet (1987) 0.77
Antibodies against oxidised low-density lipoprotein in juvenile chronic arthritis. Scand J Rheumatol (1995) 0.77
High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products. Thromb Haemost (1994) 0.77
Can ethanol intoxication affect hemocoagulation to increase the risk of brain infarction in young adults? Neurology (1983) 0.77
Familial clustering of defective release of t-PA. Br J Haematol (1991) 0.77
Enzyme-linked antiglobulin test: an accurate and simple method to quantify red cell antibodies. Transfusion (1980) 0.77
Low platelet arachidonic acid in young patients with brain infarction. Thromb Res (1987) 0.77
Effects of purified fish oil on platelet lipids and function in diabetic women. Clin Chim Acta (1987) 0.77
Failure to detect heterophile antigens in Epstein-Barr virus-infected cells and to demonstrate interaction of heterophile antibodies with Epstein-Barr virus. Clin Exp Immunol (1974) 0.76
Association of the fatty acid composition of serum phospholipids with hemostatic factors. Arterioscler Thromb Vasc Biol (1997) 0.76
Factors affecting plasma beta-thromboglobulin in diabetes mellitus. Med Biol (1980) 0.76
Fibrinogenemia Tampere--a dysfibrinogenemia with defective gelation and thromboembolic disease. Thromb Res (1995) 0.76
Nea, new blood group antigen in Finland. Vox Sang (1981) 0.76
Hemophilia B: diagnostic value of RFLP analysis in 19 of the 20 known Finnish families. Clin Genet (1990) 0.76
Payment for blood donations. BMJ (1994) 0.75
A serum inhibitor of the heterophile antibody in infectious mononucleosis. Clin Exp Immunol (1974) 0.75
[Spurring into the wind]. Duodecim (2000) 0.75
Dysfibrinogenemia associated with thrombosis and third-trimester fetal loss. A case report. J Reprod Med (1991) 0.75
A new genetic polymorphism of human serum: 2 macroglobulin (AL-M). Am J Hum Genet (1972) 0.75
Serum antibodies to oxidised low-density lipoprotein. Lancet (1994) 0.75
[Erythromelalgia]. Duodecim (1987) 0.75
Heparin rebound: a comparative study of protamine sulfate and protamine chloride in CABG surgery. J Cardiothorac Anesth (1989) 0.75
[Hepatitis B: prevention]. Suom Hammaslaakarilehti (1991) 0.75
The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis (1993) 0.75
[Purpura]. Duodecim (1973) 0.75
Post-transfusion hepatitis. Ann Med (1991) 0.75
Transmission of hepatitis C virus to sexual partners of seropositive patients with bleeding disorders: a rare event. Scand J Infect Dis (1991) 0.75
[Primary venous thrombosis of the upper limbs]. Duodecim (1990) 0.75
Prevention of navel bleeding in piglets by preparturient administration of ascorbic acid. Vet Rec (1979) 0.75
[Diagnosis of hemophilia A and B by recombinant DNA methods]. Duodecim (1987) 0.75
Tolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patients. Vox Sang (1995) 0.75
[HIV infection in Finland]. Katilolehti (1987) 0.75
Lack of evidence of HTLV-I antibodies in the Finnish population. Scand J Infect Dis (1989) 0.75
Post-transfusion hepatitis after open-heart surgery in Finland--a prospective study. Transfus Med (1991) 0.75
[Tumor hemorrhages]. Duodecim (1978) 0.75
[Retinal lesions in HIV seropositive patients]. J Fr Ophtalmol (1989) 0.75
Risk of HCV infection in haemophiliacs treated with a dry-heated factor VIII concentrate. Thromb Haemost (1992) 0.75
Post-transfusion hepatitis C in Finland. Transfus Med (1991) 0.75
[Short-acting fibrinolysis in the etiology of venous thrombosis]. Duodecim (1988) 0.75
Familial hypofibrinolysis and venous thrombosis. Br J Haematol (1989) 0.75
Achieving self sufficiency in blood across Europe. BMJ (1998) 0.75